The Medical Device Business Journal — Medical Device News & Articles | MassDevice
Click to play podcast
Maybe the only mistake Boston Scientific (NYSE:BSX) made when they hired Michael Mahoney as CEO was waiting so long to do it.
After spending much of the last half of a decade in a turnaround that never seemed to get off the ground, the medical device goliath seems to be on the up and up.
In talking about his company’s newly launched MicroCam laparoscopic imaging platform, Sanovas CEO Larry Gerrans tells a story of innovation and, perhaps more importantly, of evolution.
There’s a vast trove of potentially valuable data salted throughout the U.S. healthcare system, but as yet nobody’s figured out how to connect the data silos to leverage the power of "Big Data" in a significant way.
Two years ago, Troy Kirchenbauer got an opportunity most employees would shy away from – the chance to put his company out of business.
The former Novation executive and current general manager of Aptitude LLC, a new web portal spunout of the Irving, TX.-based group purchasing organization, was tasked with leading a team with the mission of tearing apart not only Novation’s business model, but the method by which hospitals buy billions of dollars of medical equipment every year.
Two decades after he jumped ship from the Boston Consulting Group into the orthopedic world, the business of bones and joints still fascinates Jeff Binder, despite some of the headwinds the industry has faced over the past 5 years.
Maybe that’s because the CEO of Warsaw, Ind.-based Biomet, a privately held orthopedic medical device company, is experienced enough to know the industry has been counted out before.
Brian Farley knows a little something about building a successful medical device company from the ground up.
Back in 1995 Farley was the 1st employee of VNUS Medical Technologies, which developed a catheter-based treatment for venous insufficiency. During his tenure as VNUS CEO, the company went public in 2004 before being acquired by Covidien (NYSE:COV) for $440 million.
Third Rock Ventures, one of the premiere healthcare venture capital firms, is loaded for bear again.
The Boston-based VC group recently closed its 3rd fund, a $516 million tranche that will go towards launching some 15 to16 new life science companies in the coming months. In the past 6 years Third Rock Ventures has raised more than $1.3 billion and launched some 31 companies across the life sciences spectrum.
Even before the spine surgery he claims saved his life, Bill Walton’s body was a marvel of medicine.
The Hall of Fame basketball player, who counts 2 NCAA national titles and 2 NBA championship rings to his name, has undergone 36 surgeries by his count, including 2 ankle fusions and a plethora of knee and foot procedures.
Despite that dubious pedigree, Walton told MassDevice.com that he was unprepared for the overwhelming nerve pain from a degenerative disc in his back that left him on the floor for nearly 3 years.
Veteran cardiologist Dr. Robert Hauser is eager for change, even if he has to go straight to Capitol Hill himself to make it happen.
The patient safety advocate and vocal critic of the FDA announced at this year’s American College of Cardiology conference that he’s working on a proposal to fundamentally change the way federal regulators monitor medical devices and drugs once they hit the market.
MassDevice.com sat down with Boston Scientific (NYSE:BSX) CFO Jeffrey Capello in New York City this week on the heels of the medical device company’s analyst day to discuss its outlook for 2013 and beyond.
Being one of the smallest players on the field means you’ve got to differentiate yourself to stand out against the titans of the game, and that’s what Direct Flow Medical CEO Bernie Lyons aims to do.
